Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29259024 | 0.73 | — | — | |
| SCHEMBL11526935 | 0.67 | POLB (0.38) | MEN1KMT2ANPSR1MAPTHTT | |
| SCHEMBL3825916 | 0.65 | MAPT (0.31) | MEN1KMT2AMAPTHTTSMN1; SMN2 | |
| SCHEMBL10041138 | 0.64 | — | — | |
| SCHEMBL13515254 | 0.62 | TP53 (0.42) | MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL9418987 | 0.62 | — | — | |
| SCHEMBL1784662 | 0.62 | — | — | |
| SCHEMBL9731383 | 0.58 | LMNA (0.31) | — | |
| SCHEMBL12589512 | 0.58 | — | — | |
| SCHEMBL1562353 | 0.58 | TSHR (0.38) | HTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118215654-A | AHR agonists | 伊莱利利公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-118063648-A | Solid catalyst component for propylene polymerization and propylene polymerization catalyst system | 中国石油天然气股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| EP-3800185-B1 | METHOD FOR MANUFACTURING SALACINOL | FUJIFILM CORP (JP) | 2024-02-14 | — | — | EP | disclosed |
| EP-3800185-A1 | METHOD FOR MANUFACTURING SALACINOL | FUJIFILM Corporation (JP) | 2021-04-07 | — | — | EP | disclosed |
| EP-3521279-B1 | METHODS FOR PROTECTING AND DEPROTECTING A DIOL GROUP | FUJIFILM CORP (JP) | 2021-03-03 | — | — | EP | disclosed |
| EP-3121170-B1 | COMPOUND USEFUL FOR MANUFACTURING SALACINOL, METHOD FOR MANUFACTURING THE COMPOUND, METHOD FOR MANUFACTURING SALACINOL, METHODS FOR PROTECTING AND DEPROTECTING DIOL GROUP, AND PROTECTIVE AGENT FOR DIOL GROUP | FUJIFILM CORP (JP) | 2019-11-13 | — | — | EP | disclosed |
| US-10428042-B2 | Compound useful for manufacturing salacinol, method for manufacturing the compound, method for manufacturing salacinol, methods for protecting and deprotecting diol group, and protective agent for diol group | FUJIFILM CORPORATION (JP) | 2019-10-01 | — | — | US | disclosed |
| EP-3521279-A1 | METHODS FOR PROTECTING AND DEPROTECTING A DIOL GROUP | Fujifilm Corporation (JP) | 2019-08-07 | — | — | EP | disclosed |
| US-20180327378-A1 | COMPOUND USEFUL FOR MANUFACTURING SALACINOL, METHOD FOR MANUFACTURING THE COMPOUND, METHOD FOR MANUFACTURING SALACINOL, METHODS FOR PROTECTING AND DEPROTECTING DIOL GROUP, AND PROTECTIVE AGENT FOR DIOL GROUP | FUJIFILM CORPORATION (JP) | 2018-11-15 | — | — | US | disclosed |
| US-10059686-B2 | Compound useful for manufacturing salacinol, method for manufacturing the compound, method for manufacturing salacinol, methods for protecting and deprotecting diol group, and protective agent for diol group | FUJIFILM CORPORATION (JP) | 2018-08-28 | — | — | US | disclosed |
| US-20030064962-A1 | Inhibitors of hepatitis C virus NS3 protease | BRISTOL-MYERS SQUIBB COMPANY (FORMERLY D/B/A DUPONT PHARMACEUTICALS COMPANY) | 2003-04-03 | — | — | US | disclosed |
| WO-2002048116-A2 | INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2002-06-20 | — | — | WO | disclosed |
| EP-0773930-B1 | AROMATIC AMINO ETHERS AS PAIN RELIEVING AGENTS | ZENECA LTD (GB) | 2000-10-11 | — | — | EP | disclosed |
| EP-0733033-B1 | PHARMACEUTICALLY ACTIVE SUBSTITUTED AROMATIC COMPOUNDS | ZENECA LTD (GB) | 1999-12-22 | — | — | EP | disclosed |
| US-5843942-A | Aromatic amino ethers as pain relieving agents | ZENECA LIMITED (GB) | 1998-12-01 | — | — | US | disclosed |
| US-5811459-A | PAIN RELIEVERS | ZENECA LIMITED (GB) | 1998-09-22 | — | — | US | disclosed |
| EP-0773930-A1 | AROMATIC AMINO ETHERS AS PAIN RELIEVING AGENTS | ZENECA LIMITED (GB) | 1997-05-21 | — | — | EP | disclosed |
| EP-0733033-A1 | PHARMACEUTICALLY ACTIVE SUBSTITUTED AROMATIC COMPOUNDS | ZENECA LIMITED (GB) | 1996-09-25 | — | — | EP | disclosed |
| WO-1996011902-A1 | PHARMACEUTICALLY ACTIVE SUBSTITUTED AROMATIC COMPOUNDS | ZENECA LIMITED (GB) | 1996-04-25 | — | — | WO | disclosed |
| WO-1996003380-A1 | AROMATIC AMINO ETHERS AS PAIN RELIEVING AGENTS | ZENECA LIMITED (GB) | 1996-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030064962-A1 | Inhibitors of hepatitis C virus NS3 protease | PRSS1, SERPINB1, SPINT2 | MEN1 3568/4885KMT2A 3760/4885NPSR1 3667/4885 |
| US-10059686-B2 | Compound useful for manufacturing salacinol, method for manufacturing the compound, method for manufacturing salacinol, methods for protecting and deprotecting diol group, and protective agent for diol group | SPTSSB, ADH1A, DHCR7 | MEN1 980/4885KMT2A 1337/4885NPSR1 4394/4885 |
| US-10428042-B2 | Compound useful for manufacturing salacinol, method for manufacturing the compound, method for manufacturing salacinol, methods for protecting and deprotecting diol group, and protective agent for diol group | SPTSSB, DHCR7, ADH1A | MEN1 1012/4885KMT2A 1385/4885NPSR1 4391/4885 |
| US-20180327378-A1 | COMPOUND USEFUL FOR MANUFACTURING SALACINOL, METHOD FOR MANUFACTURING THE COMPOUND, METHOD FOR MANUFACTURING SALACINOL, METHODS FOR PROTECTING AND DEPROTECTING DIOL GROUP, AND PROTECTIVE AGENT FOR DIOL GROUP | SPTSSB, DHCR7, ADH1A | MEN1 1012/4885KMT2A 1385/4885NPSR1 4391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.